IP Library Granted Patent US 7,355,036
Granted Patent B2
US 7,355,036 · App. 10/482,744 · Granted Apr 8, 2008

Two-stage protective groups for the synthesis of biopolymers

Assignee: Febit AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,355,036
App. No.
10/482,744
Granted
Apr 8, 2008
Kind
B2
Abstract

The invention relates to a method for the synthesis of a nucleic acid by gradual breakdown from protected synthesis building blocks carrying two-stage protective groups. The two-stage protective groups are split by means of a first exposure step and a subsequent chemical treatment step

Claims (48)

1. A process for the synthesis of a nucleic acid by stepwise assembly of building blocks, wherein the building blocks are building blocks for the synthesis of a nucleic acid, wherein at least one of the building blocks carries a two-stage protective group, wherein the two-stage protective group contains a photoactivatable group selected from the group consisting of nitroveratryloxycarbonyl (NVOC), α-methyl-6-nitropiperonyloxycarbonyl (MeNPOC), 3,5 -dimethoxybenzoincarbonate (DMBOC), 2-(o-nitrophenyl)propyloxycarbonyl (NPPOC), o-nitrobenzyl and 2-(o-nitrophenyl) ethyl, wherein the photoactivable group is removed by an illumination step and the remainder of the two-stage protective group is removed by a subsequent acid treatment step.

2. The process as claimed in claim 1 , characterized in that the building block with the two-stage protective group has the general formula I:

where R 1 and R 2 are each independently selected from hydrogen, OR 3, O(CH 2 ) n COOR 3 and NHZ,

R 3 comprises a C 1 -C 8 alkyl group, a C 2 -C 8 alkenyl group, a C 2 -C 8 alkynyl group or/and C 6 -C 20 aryl group which may optionally have substituents,

X is the building block,

Y is in each case independently the photoactivatable group,

Z is an amino-protective group,

n is an integer from 0 to 4, and

where R 1 or/and R 2 may optionally be replaced by Y.

3. The process as claimed in claim 2 , characterized in that a two-stage protective group which carries at least one fluorescent group is used.

4. The process as claimed in claim 3 , characterized in that Y, R 3 or/and Z carry the fluorescent group.

5. The process as claimed in claim 1 , characterized in that the building blocks are phosphoramidites.

6. The process as claimed in claim 5 , characterized in that phosphoramidite building blocks carry the two-stage protective group on the 5′-O atom.

7. The process as claimed in claim 1 , wherein at least one of the building blocks contains a spacer or linker group.

8. The process as claimed in claim 1 , characterized in that the synthesis is carried out on a solid phase.

9. The process as claimed in claim 8 , characterized in that a site-dependent synthesis of a plurality of nucleic acids, each with a different nucleotide sequence, is carried out on a single support.

10. A compound of the general formula I:

where R 1 and R 2 are each independently selected from hydrogen, OR 3, O(CH 2 ) n COOR 3 and NHZ,

R 3 comprises a C 1 -C 8 alkyl group, a C 2 -C 8 alkenyl group, a C 2 -C 8 alkynyl group or/and C 6 -C 20 aryl group which may optionally have substituents,

X is a building block for the synthesis of a nucleic acid or a leaving group,

Y is in each case independently a photoactivatable group,

Z is an amino-protective group,

n is an integer from 0 to 4,

where R 1 or/and R 2 may optionally be replaced by Y, and

wherein the photoactivatable group is selected from the group consisting of nitroveratryloxycarbonyl (NVOC), α-methyl-6-nitropiperonyloxycarbonyl (MeNPOC), 3,5-dimethoxybenzoincarbonate (DMBOC), 2-(o-nitrophenyl)propyloxycarbonyl (NPPOC), o-nitrobenzyl and 2-(o-nitrophenyl) ethyl and wherein the photoactivatable group is removable by illumination.

11. The compound as claimed in claim 10 , characterized in that it carries at least one fluorescent group.

12. The compound as claimed in claim 11 , characterized in that Y, R 3 or/and Z carry a fluorescent group.

13. A method of synthesizing a nucleic acid from building blocks, wherein at least one of the building blocks is protected by a two-stage protective group, wherein the at least one of the building blocks protected by a two-stage protective group is a compound of Formula (I), said method comprising the steps of:

removing a photoactivatable group of the two-stage protective group by illumination, and

subsequently removing the rest of the two-stage protective group from the building block by acid treatment

wherein formula (I) is

where R 1 and R 2 are each independently selected from hydrogen, OR 3, O(CH 2 ) n COOR 3 and NHZ,

R 3 comprises a C 1 -C 8 alkyl group, a C 2 -C 8 alkenyl group, a C 2 -C 8 alkynyl group or/and C 6 -C 20 aryl group which may optionally have substituents,

X is a building block for the synthesis of a nucleic acid or a leaving group,

Y is in each case independently a photoactivatable group,

Z is an amino-protective group,

n is an integer from 0 to 4,

where R 1 or/and R 2 may optionally be replaced by Y, and

wherein the photoactivatable group is selected from the group consisting of nitroveratryloxycarbonyl (NVOC), α-methyl-6-nitropiperonyloxycarbonyl (MeNPOC), 3,5-dimethoxybenzoincarbonate (DMBOC), 2-(o-nitrophenyl)propyloxycarbonyl (NPPOC), o-nitrobenzyl and 2-(o-nitrophenyl) ethyl and wherein the photoactivatable group is removable by illumination.

14. The process of claim 2 , wherein the substituent is selected from the group consisting of a halogen, —OH, —SH, —O—, —S(O)—, —S(O) 2 —, —NO 2, —CN and —NHZ, wherein Z is an amino-protective group.

15. The compound of claim 10 , wherein the substituent is selected from the group consisting of a halogen, —OH, —SH, —O—, —S(O)—, —S(O) 2 —, NO 2, —CN and —NHZ, wherein Z is an amino-protective group.

16. The method of claim 13 , wherein the substituent is selected from the group consisting of a halogen, —OH, —SH, —O—, —S(O)—, —S(O) 2 —, —NO 2, —CN and —NHZ, wherein Z is an amino-protective group.

17. The method of claim 13 , characterized in that the compound of formula I carries at least one fluorescent group.

18. The method of claim 17 , characterized in that Y, R 3 or/and Z carry a fluorescent group.

19. The compound of claim 10 , characterized in that the building block is a phosphoramidite.

20. The compound of claim 19 , characterized in that the linkage with the phosphoramidite building block is through the 5′-O atom.

21. The process of claim 13 , characterized in that the building blocks are phosphoramidites.

22. The process of claim 21 , characterized in that phosphoramidite building blocks carry the two-stage protective group on the 5′-O atom.

Assignments (7)
ASSETS PURCHASE Recorded Dec 30, 2009
From: FEBIT AG
To: MR. CHRISTOPHER SEAGON, ESQ.
Reel/Frame 023708/0737 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 30, 2009
From: TECHNOSTART CONSULTING FIRM FOR INVESTMENTS FUNDS MBH
To: NECKARBURG 66 V V GMBH
Reel/Frame 023708/0760 →
CHANGE OF NAME Recorded Dec 30, 2009
From: NECKARBURG 66. V. V. GMBH
To: FEBIT BIOTECH GMBH
Reel/Frame 023708/0789 →
CHANGE OF NAME Recorded Dec 30, 2009
From: FEBIT BIOTECH GMBH
To: FEBIT HOLDING GMBH
Reel/Frame 023708/0796 →
ASSETS PURCHASE Recorded Dec 30, 2009
From: MR. CHRISTOPHER SEAGON, ESQ.
To: TECHNOSTART CONSULTING FIRM FOR INVESTMENTS FUNDS MBH
Reel/Frame 023720/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2004
From: GUIMIL, RAMON; SCHEFFLER, MATTHIAS; STAHLER, PEER F.; BEIJER, BARBO
To: FEBIT AG
Reel/Frame 015402/0134 →
MERGER Recorded May 6, 2002
From: SIEMENS MEDICAL SYSTEMS, INC.
To: SIEMENS MEDICAL SOLUTIONS USA, INC.
Reel/Frame 012876/0262 →
Priority Claims (1)
DE 101 32 025 · Jul 3, 2001 · national
Continuity (2)
Provisional Application 6031430600 · Aug 24, 2001
Related Publication 20040197851A1 · Oct 7, 2004